Cover Image
市場調查報告書

感染疾病診斷檢驗的全球市場:2015年∼2019年

Global Infectious Disease Diagnostics Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 342118
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
感染疾病診斷檢驗的全球市場:2015年∼2019年 Global Infectious Disease Diagnostics Testing Market 2015-2019
出版日期: 2015年10月14日 內容資訊: 英文 75 Pages
簡介

全球感染疾病診斷檢驗市場預測從2014年∼2019年間將以年複合成長率(CAGR)11.48%的速度成長。

本報告提供全球感染疾病診斷檢驗市場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗証,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

  • 焦點

第2章 調查範圍

  • 市場概要
  • 主要供應商產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 主要市場焦點

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各技術

  • 分子診斷檢驗
  • POC感染疾病診斷檢驗

第7章 市場區隔:各應用

  • 各應用
  • 呼吸系統
  • HIV
  • 醫療相關感染疾病
  • 性的健康
  • 熱帶病
  • 肝臟感染疾病

第8章 市場區隔:各產品

  • 檢測套組·消耗品
  • 檢查裝置
  • 服務

第9章 地理區分

  • 南北美洲
  • 歐洲·中東·非洲
  • 亞太地區

第10章 推動市場要素

第11章 推動因素的影響

第12章 市場課題

第13章 推動因素與課題的影響

第14章 市場趨勢

第15章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他卓越供應商

第16章 主要供應商分析

  • Abbott Diagnostics
  • Alere
  • bioMerieux
  • DiaSorin
  • Roche Diagnostics

第17章 附錄

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR7387

About infectious disease diagnostic

Infectious diseases are disorders caused by micro-organisms such as viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defense system or can directly target the causative agent. Infectious diseases such as bacterial infections, respiratory diseases, HPV, and HIV are gradually increasing worldwide. For instance, based on the study of WHO global health observatory (GHO) data, it is estimated that in 2013 34-38 million people suffered from HIV infection worldwide. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Infectious disease diagnostic tests help in detecting new pathogens and specific pathogens, monitoring response to therapy, assessing prognosis, and determining appropriate treatment.

Technavio's analysts forecast the global infectious disease diagnostic testing market to grow at a CAGR of 11.48% over the period 2014-2019.

Covered in this report

The report covers the present scenario and growth prospects of the global infectious disease diagnostic testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following product categories:

  • Molecular diagnostic test
  • POC infectious disease diagnostics test

POC infectious disease diagnostics test is classified into the following based on application:

  • Respiratory
  • HIV
  • HAIs
  • Sexual health
  • Tropical diseases
  • Liver

Technavio's report, Global Infectious Disease Diagnostic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global infectious disease diagnostic testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Abbott Diagnostic
  • Alere
  • bioMerieux
  • Diasorin
  • Roche Diagnostic

Other Prominent Vendors

  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Corgenix
  • Diaxonhit
  • Eiken Chemical
  • EMD Millipore
  • Epitope Diagnostic
  • EUROIMMUN
  • Gold Standard Diagnostics
  • Hologic
  • Immunetics
  • InBios International
  • J.Mitra
  • Meridian Bioscience
  • OraSure Technologies
  • ORGENTEC Diagnostika
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Quidel
  • Siemens Healthcare Diagnostics
  • TECHLAB
  • Thermo Fisher Scientific
  • Trinity Biotech

Key market driver

  • Increase in prevalence of infectious diseases
  • For a full, detailed list, view our report

Key market challenge

  • Emerging infectious diseases
  • For a full, detailed list, view our report

Key market trend

  • Advances in technology
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by technology

  • Molecular diagnostic tests
  • POC infectious disease diagnostic tests

PART 07: Market segmentation by application

  • Global POC infectious disease diagnostic testing market by application
  • Respiratory
  • HIV
  • Healthcare-associated infections
  • Sexual health
  • Tropical diseases
  • Liver infections

PART 08: Market segmentation by product

  • Assay kits and consumables
  • Instruments
  • Services

PART 09: Geographical segmentation

  • Infectious disease diagnostic testing market in Americas
  • Infectious disease diagnostic testing market in EMEA
  • Infectious disease diagnostic testing market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • Abbott Diagnostics
  • Alere
  • bioMerieux
  • DiaSorin
  • Roche Diagnostics

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global infectious disease diagnostic testing market by technology
  • Exhibit 05: Global infectious disease molecular diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 06: Global POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 07: Segmentation of global POC infectious disease diagnostic testing market by application 2014
  • Exhibit 08: Global respiratory POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 09: Demographic statistics for HIV 2014
  • Exhibit 10: Global HIV POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 11: Global HAIs POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 12: Global sexual health POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 13: Global tropical disease POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 14: Global liver POC infectious disease diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 15: Global POC infectious disease diagnostic testing market by application 2014-2019
  • Exhibit 16: Segmentation of global infectious disease diagnostic testing by product
  • Exhibit 17: Segmentation of global infectious disease testing market by product 2014
  • Exhibit 18: Segmentation of global infectious disease diagnostic testing market by geography 2014
  • Exhibit 19: Segmentation of global infectious disease diagnostic testing market by geography 2019
  • Exhibit 20: Segmentation of global infectious disease diagnostic testing market by geography 2014-2019
  • Exhibit 21: Infectious disease diagnostic testing market in Americas 2014-2019 ($ billions)
  • Exhibit 22: Infectious disease diagnostic testing market in EMEA 2014-2019 ($ billions)
  • Exhibit 23: Infectious disease diagnostic testing market in APAC 2014-2019 ($ billions)
  • Exhibit 24: Impact of drivers
  • Exhibit 25: Impact of drivers and challenges
  • Exhibit 26: Key takeaways: Abbott Diagnostics
  • Exhibit 27: Key takeaways: Alere
  • Exhibit 28: Key takeaways: bioMerieux
  • Exhibit 29: Key takeaways: DiaSorin
  • Exhibit 30: Key takeaways: Roche Diagnostics
  • Exhibit 31: Abbott Diagnostics: Key business offerings
  • Exhibit 32: Alere: Business segmentation by revenue 2014
  • Exhibit 33: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 34: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
  • Exhibit 35: bioMerieux: Applications by technology
  • Exhibit 36: DiaSorin: Business segmentation by revenue 2014
  • Exhibit 37: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 38: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 39: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 40: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 41: Roche Diagnostics: Geographical segmentation by revenue 2014
Back to Top